Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-3-19
pubmed:abstractText
Current detection methods (computed tomography, ultrasound, and MRI) for hepatocarcinogenesis in humans rely on visual confirmation of neoplastic formations. A more effective early detection method is needed. Using in vivo magnetic resonance spectroscopy (MRS), we show that alterations in the integral ratios of the bis-allyl to vinyl hydrogen protons in unsaturated lipid fatty acyl groups correlate with the development of neoplastic formations in vivo in a TGFalpha/c-myc mouse hepatocellular carcinoma (HCC) model. HPLC analysis of the TGFalpha/c-myc mice liver tissue revealed a significant increase in the amount of oleic acid, along with alterations in linoleic and gamma-linolenic acids, as compared with control CD1 mice. Electrospray ionization tandem mass spectrometry analysis indicated a significant increase in the abundance of specific glycerol phosphatidylcholine (GPCho) lipids containing palmitic and oleic acids between control CD1 and TGFalpha/c-myc mice liver tissue extracts. Western blot analysis of the mice liver tissue indicates alterations in the desaturase enzyme stearoyl CoA desaturase (SCD)1, responsible for palmitic and oleic acid formation. Microarray analysis detected alterations in several genes involved with fatty acid metabolism, particularly SCD2, in transgenic mouse liver tissue. In correlation with the HPLC, mass spectrometry, Western blot, and microarray analyses, we are able to confirm the ability of in vivo MRS to detect precancerous lesions in the mouse liver before visual neoplastic formations were detectable by MRI.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-10913831, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-11290839, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-11323400, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-11410331, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-11478382, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-12353259, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-12353260, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-12451583, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-12458622, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-13428781, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-14648561, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-14668230, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-15096706, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-15389848, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-15805070, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-1601527, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-16230047, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-16315208, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-16413201, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-16523527, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-17854108, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-17872998, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-17969083, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-18474264, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-2864701, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-8467484, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-8755630, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-9395466, http://linkedlifedata.com/resource/pubmed/commentcorrection/19065002-9514943
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-2275
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
611-22
pubmed:dateRevised
2010-9-23
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse model.
pubmed:affiliation
Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural